Publication Year

Kelsh MA, Bracken TD, Sahl JD, Shum M, Ebi KL. 2003. Occupational magnetic field exposures of garment workers: Results of personal and survey measurements. Bioelectromagnetics 24(5):316–326; doi: 10.1002/bem.10112. PMID: 12820289.

Crump C, Crump K, Hack E, Luippold R, Mundt K, Liebig EW, Panko JM, Paustenbach DJ, Proctor DM. 2003. Dose-response and risk assessment of airborne hexavalent chromium and lung cancer mortality. Risk Anal 23(6):1147–1163; doi: 10.1111/j.0272-4332.2003.00388.x. PMID: 14641890.

Martin EA, Gaskell M, Al-Azzawi F, Garner RC, Brown K, Boocock DJ, Mattock E, Pring DW, Dingley K, et al. 2003. Tamoxifen DNA damage detected in human endometrium using the ultra sensitive technique of accelerator mass spectrometry. Cancer Res 63(23):8461–8465. PMID: 14679010.

Grasty RC, Grey BE, Lau CS, Rogers JM. 2003. Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. Birth Defects Res B 68(6):465–471; doi: 10.1002/bdrb.10046. PMID: 14745980.

Gentry PR, Covington TR, Clewell HJ, Andersen ME. 2003. Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone. J Toxicol Environ Health A 66(23):2209–2225; doi: 10.1080/713853996. PMID: 14612334.

Haws L. Combustion risk modeling and assessment. Presented at the Texas Commission on Environmental Quality Workshop on Hazardous Waste Combustion, Austin, TX, May 2003.

Proctor D, Panko J, Liebig E, Mundt K, Buczynski M, Barnhart R, Harris MA, Morgan R, Finley B, Paustenbach D. 2003. Workplace concentrations of airborne hexavalent chromium for the Painesville, Ohio chromate production plant. Appl Occup Environ Hyg 18(6):430-449; doi: 10.1080/10473220301421. PMID: 12746066.

Perry CS. Process for development of protective concentration levels for remediation sites in Texas. Presented at Society for Environmental Toxicology and Chemistry (SETAC) meeting, Austin, TX, November 2003.

Kelsh MA, Buffler P, Daaboul J, Rutherford G, Lau E, Exuzides KE, et al. 2003. Primary congenital hypothyroidism and newborn thyroid function among residents of a Southern California community. J Occup Environ Med 45(10):1116–1127; doi: 10.1097/01.jom.0000091683.25325.55. PMID: 14534454.

Barr ML, Schenkel FA, Van Kirk A, Halbert RJ, Helderman JH, Hricik DE, Matas AJ, Nordyke RJ. 2003. Determinants of quality of life changes among long-term cardiac transplant survivors: Results from longitudinal data. J Heart Lung Trans 22(10):1157-67; doi: 10.1016/s1053-2498(02)01224-x. PMID: 14550826.

Rogers JM, Abbott BD. 2003. Screening for developmental toxicity of tobacco smoke constituents. Toxicol Sci 75(2):227–228; doi: 10.1093/toxsci/kfg215. PMID: 14521141.

Sarangapani R, Gentry PR, Covington TR, Teeguarden JG, Clewell HJ. 2003. Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors. Inhal Toxicol 15(10):987–1016; doi: 10.1080/08958370390226350. PMID: 12928976.

Rogers EH, Hunter ES, Rosen MB, Rogers JM, Lau C, Hartig PC, Francis BM, Chernoff N. 2003. Lack of evidence for intergenerational reproductive effects due to prenatal and postnatal undernutrition in the female CD-1 mouse. Reprod Toxicol 17(5):519–525; doi: 10.1016/s0890-6238(03)00070-4. PMID: 14555189.

Birnbaum LS, Staskal DF, Diliberto JJ. 2003. Health effects of polybrominated dibenzo-p-dioxins (PBDDs) and dibenzofurans (PBDFs). Environ Int 29(6):855-860; doi: 10.1016/S0160-4120(03)00106-5. PMID: 12850101.

Staskal DF, DeVito MJ, Ross DG, Birnbaum LS. Caffeine, acetanilide, and methoxyresorufin metabolism by rat and human CYP1A2 SUPERSOMES and their inhibition by 2,3,7,8,-tetrachlorodibenzo-p-dioxin (TCDD). Dioxin 2003, Boston, MA, 2003. Organohalogen Compounds 64:324-327.

Gentry RP, Covington TR, Clewell HJ III. 2003. Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation. Regul Toxicol Pharmacol 38(1):1–16; doi: 10.1016/S0273-2300(03)00047-3. PMID: 12878049.

Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, Butenhoff JL, Stevenson LA, Lau C. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: Maternal and prenatal evaluations. Toxicol Sci 74(2):369–381; doi: 10.1093/toxsci/kfg121. PMID: 12773773.

Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, Butenhoff JL, Stevenson LA. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Postnatal evaluation. Toxicol Sci 74(2):382–292; doi: 10.1093/toxsci/kfg122. PMID: 12773772.

Tarka-Leeds DK, Herr DW, Klinefelter GR, Rogers JM. 2003. Effects of gestational exposure to ethane dimethanesulfonate in CD-1 mice: Microtia and preliminary hearing tests. Birth Defects Res B 68(4):383–390; doi: 10.1002/bdrb.10033. PMID: 14667001.

Grasty RC, Grey BE, Lau CS, Rogers JM. 2003. Window of susceptibility to perfluorooctane sulfonate (PFOS)-induced neonatal mortality in the rat. Birth Defects Research B 68(3):5.